Assignee
IMMUNE ONC THERAPEUTICS INC
US·2 granted patents·2 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0150US12559555B2Anti-LILRB4 antibodies and derivative productsIMMUNE ONC THERAPEUTICS INC·Filed 2021·Granted Feb 24, 2026·0 cites·20 claims
- 0248US2025179173A1Combination therapy of lilrb antagonist and pd-1/pd-l1 axis inhibitorIMMUNE ONC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0343US12596122B2LILRB2 antibodies and uses thereofIMMUNE ONC THERAPEUTICS INC·Filed 2021·Granted Apr 7, 2026·0 cites·26 claims
- 0442US2024002503A1Novel anti-lilrb2 antibodies and derivative productsIMMUNE ONC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →